# Walter and Eliza Hall Institute of Medical Research

> Walter and Eliza Hall Institute of Medical Research is a VC fund backing Medical. See 2 investments, check sizes, portfolio and contact details. Updated Aug…

- Type: VC Fund
- Location: Parkville, Australia
- Total investments: 2
- Last investment: Dec 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/wehi_research
- Website: https://x.com/WEHI_research
- Facebook: https://www.facebook.com/WEHIresearch

Walter and Eliza Hall Institute of Medical Research is a VC fund in Parkville focused on Medical and Biopharma. Walter and Eliza Hall Institute of Medical Research offers discoveries for cancer, infection, aging, medicines and advanced technologies.

## Contacts

5 contacts available for Walter and Eliza Hall Institute of Medical Research. Shizune tracks 2 team members at Walter and Eliza Hall Institute of Medical Research. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/walter-and-eliza-hall-institute-of-medical-research?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |
| Life Science | 1 | 50% |
| Biotechnology | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Komander | Head, Ubiquitin Signalling Division | 1 | — |
| Ueli Nachbur | Scientist Entrepreneur | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Entact Bio | Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins. | $81M | Series A | Dec 06, 2022 |  |
| Entact Bio | Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins. | $81M | Series A | Dec 06, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [4BIO Capital](https://shizune.co/investors/profile/4bio-capital-partners) — VC Fund, 2 deals together
- [Abingworth](https://shizune.co/investors/profile/abingworth-management) — VC Fund, 2 deals together
- [Arkin Bio Ventures](https://shizune.co/investors/profile/arkin-bio-ventures) — VC Fund, 2 deals together
- [Brandon Capital](https://shizune.co/investors/profile/brandon-capital-partners) — VC Fund, 2 deals together
- [Janus Henderson Investors](https://shizune.co/investors/profile/janus-henderson-investors) — VC Fund, 2 deals together
- [Logos Capital](https://shizune.co/investors/profile/logos-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Walter and Eliza Hall Institute of Medical Research invest in?

Walter and Eliza Hall Institute of Medical Research invests primarily in Medical, Biopharma and Life Science startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Walter and Eliza Hall Institute of Medical Research?

Public channels for Walter and Eliza Hall Institute of Medical Research include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Walter and Eliza Hall Institute of Medical Research?

The team at Walter and Eliza Hall Institute of Medical Research includes David Komander (Head, Ubiquitin Signalling Division) and Ueli Nachbur (Scientist Entrepreneur). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co